Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2393 (LINC02393)

Target
LINC02393
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2393 (LINC02393), also known as FLJ37505, is a human long intergenic non-coding RNA (lincRNA) located in regions of the genome that do not overlap with protein-coding genes and is longer than 200 nucleotides[1]. LincRNAs represent a major subclass of long non-coding RNAs and are distinguished by their position in the genome (intergenic) relative to protein-coding loci[1]. LincRNAs can have a variety of functions, including regulation of gene expression, chromatin remodeling, RNA stabilization, and serving as enhancers or transcriptional regulators, often in a tissue-specific manner[1]. Only a minority of annotated lincRNAs have been functionally characterized, and there is no direct evidence in current literature or curated databases to suggest that LINC02393 functions as a therapeutic target (such as a receptor, enzyme, transporter, or direct disease marker)[1]. There is also no information indicating that any drugs directly target LINC02393, nor has it been established as a diagnostic or predictive biomarker.

Other names
FLJ37505LINC02393
02

Biological functions

Regulation of gene expressionChromatin remodelingRNA stabilizationTranscription regulationPotential enhancer-associated activity[1]
03

Disease associations

Potential roles in cancer and other diseases (generic to lincRNAs; specific to LINC02393 not established in available data)[1]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2393 (LINC02393).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2393 (LINC02393).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call